MB
Michael P Bailey
President & CEODirector

Michael P Bailey insider trades: Aveo Pharmaceuticals (AVEO) stock buys and sales

President & CEO, Aveo Pharmaceuticals Last trade Sep 1, 2021 34 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2007
4
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 1, 2021AVEO↑ Buy$97K
Nov 21, 2019AVEO↑ Buy$90K
Jan 7, 2015AVEO↓ Sell$4K
Jan 30, 2014AVEO↓ Sell$9K
Jan 28, 2013AVEO↓ Sell$6K
Jan 26, 2012AVEO↓ Sell$10K
Aug 5, 2010SNTA↓ Sell$13K
Nov 19, 2007IMCL↓ Sell$946K
Jul 12, 2007IMCL↓ Sell$43K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael P Bailey's insider trades

Michael P Bailey is President & CEO at Aveo Pharmaceuticals (AVEO). Since Jul 12, 2007, Michael has reported 2 open-market purchases worth $187K and 7 sales worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (24 filings), shares returned to the company (4 filings), option exercises (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.